Clean Science & Technology Ltd
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
- Market Cap ₹ 7,985 Cr.
- Current Price ₹ 752
- High / Low ₹ 1,600 / 652
- Stock P/E 29.4
- Book Value ₹ 146
- Dividend Yield 0.80 %
- ROCE 29.3 %
- ROE 21.9 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.1%
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Promoter holding has decreased over last 3 years: -27.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE Allcap BSE Commodities BSE 250 SmallCap Index
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 | 140 | 191 | 241 | 393 | 419 | 512 | 685 | 936 | 789 | 922 | 864 | |
| 106 | 92 | 118 | 168 | 256 | 234 | 253 | 385 | 533 | 452 | 523 | 495 | |
| Operating Profit | 58 | 48 | 72 | 73 | 137 | 186 | 260 | 300 | 403 | 338 | 400 | 369 |
| OPM % | 35% | 34% | 38% | 30% | 35% | 44% | 51% | 44% | 43% | 43% | 43% | 43% |
| 3 | 2 | 4 | 5 | 11 | 11 | 25 | 30 | 39 | 38 | 36 | 39 | |
| Interest | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 5 | 6 | 6 | 8 | 11 | 14 | 17 | 25 | 36 | 44 | 44 | 44 |
| Profit before tax | 53 | 41 | 70 | 70 | 137 | 182 | 267 | 305 | 405 | 331 | 391 | 363 |
| Tax % | 34% | 34% | 33% | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 25% | |
| 35 | 27 | 47 | 49 | 98 | 140 | 198 | 229 | 304 | 248 | 292 | 272 | |
| EPS in Rs | 247.58 | 192.41 | 330.79 | 343.72 | 690.82 | 1,051.82 | 18.68 | 21.52 | 28.57 | 23.31 | 27.51 | 25.57 |
| Dividend Payout % | 10% | 13% | 12% | 12% | 15% | 2% | 134% | 15% | 18% | 21% | 22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 17% |
| 3 Years: | 10% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 16% |
| 3 Years: | 9% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 29% |
| 3 Years: | 25% |
| Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 76 | 99 | 143 | 186 | 271 | 341 | 529 | 758 | 1,008 | 1,205 | 1,446 | 1,545 |
| 20 | 12 | 0 | 1 | 3 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | |
| 29 | 27 | 35 | 48 | 53 | 85 | 120 | 156 | 139 | 154 | 147 | 156 | |
| Total Liabilities | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 | 1,713 |
| 60 | 64 | 77 | 101 | 126 | 166 | 186 | 296 | 427 | 401 | 364 | 351 | |
| CWIP | 0 | 0 | 2 | 1 | 4 | 3 | 55 | 44 | 4 | 2 | 4 | 5 |
| Investments | 1 | 1 | 32 | 18 | 76 | 134 | 233 | 247 | 428 | 666 | 907 | 1,076 |
| 65 | 75 | 68 | 115 | 122 | 127 | 187 | 338 | 300 | 302 | 330 | 281 | |
| Total Assets | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 | 1,713 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 69 | 45 | 85 | 160 | 193 | 127 | 299 | 277 | 279 | |||
| -52 | -17 | -94 | -106 | -186 | -124 | -245 | -228 | -221 | |||
| -15 | -5 | -11 | -55 | -6 | -0 | -55 | -53 | -52 | |||
| Net Cash Flow | 2 | 23 | -20 | -1 | 1 | 4 | -0 | -3 | 6 | ||
| Free Cash Flow | -33 | 13 | 46 | 109 | 109 | -2 | 164 | 264 | 270 | ||
| CFO/OP | 124% | 91% | 88% | 109% | 100% | 65% | 98% | 105% | 94% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36 | 68 | 41 | 60 | 55 | 61 | 53 | 82 | 58 | 75 | 73 |
| Inventory Days | 202 | 246 | 165 | 93 | 79 | 98 | 156 | 143 | 122 | 146 | 118 |
| Days Payable | 71 | 79 | 73 | 85 | 48 | 101 | 180 | 166 | 90 | 121 | 83 |
| Cash Conversion Cycle | 166 | 235 | 134 | 69 | 87 | 58 | 29 | 59 | 89 | 100 | 108 |
| Working Capital Days | 87 | 131 | 64 | 61 | 62 | 33 | 32 | 90 | 66 | 78 | 79 |
| ROCE % | 42% | 55% | 42% | 59% | 59% | 61% | 47% | 45% | 29% | 29% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Total Installed Manufacturing Capacity MTPA |
|
||||||
| Actual Production Volume MT |
|||||||
| Capacity Utilization Rate % |
|||||||
| Global Market Share - FMCG Chemicals % |
|||||||
| Global Market Share - Performance Chemicals % |
|||||||
| HALS Sales Volume Tons |
|||||||
| Renewable Energy Share in Power Consumption % |
|||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI Listing Regulations, 2015, Investment In Clean Fino-Chem Limited - Wholly Owned Subsidiary
8 Apr - CSTL subscribed to 8,36,121 CFCL shares for Rs 50.00 crore to fund projects.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - RTA confirms no dematerialization requests received for quarter ended 31 March 2026.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
1 Apr - Krishnakumar reappointed WTD 1 Apr 2026–31 Mar 2031; Ashok WTD‑EVC 1 Apr 2026–27 Jul 2027; Siddhartha MD 1 Apr 2026–31 Mar 2031.
- Closure of Trading Window 25 Mar
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
17 Mar - Allotment of 800 Equity Shares under CSTL ESOS 2021 of the Company.
Annual reports
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Jul 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Jan 2024TranscriptAI SummaryPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Product Segment [1]
1) Performance Chemicals (69% in FY25 vs 69% in FY22): It manufactures Monomethyl Ether of Hydroquinone (MEHQ), used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.